Immutep shares are trading lower after Baird maintained an Outperform rating on the stock but lowered its price target from $7 to $6.
Portfolio Pulse from Benzinga Newsdesk
Immutep shares are trading lower after Baird maintained an Outperform rating on the stock but lowered its price target from $7 to $6.

June 27, 2024 | 11:38 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Immutep shares are trading lower after Baird maintained an Outperform rating on the stock but lowered its price target from $7 to $6.
The reduction in the price target from $7 to $6 by Baird, despite maintaining an Outperform rating, suggests a more cautious outlook on the stock's near-term performance. This has led to a negative reaction in the market, causing the shares to trade lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100